Ckd Bio (063160) — Cash Flow Quality Index
Latest as of March 2025:
-5.50x
Ckd Bio (063160) has a Cash Flow Quality Index of -5.50x as of March 2025. Operating cash flow of ₩-4.95 Billion is below net income of ₩900.16 Million, suggesting accrual-heavy earnings not yet converted to cash. Explore 063160 debt coverage from operations to assess how comfortably operating cash covers total debt obligations.
Cash Flow Quality Index
-5.50x
Operating CF / Net Income
Operating Cash Flow
₩-4.95 Billion
KRW
Net Income
₩900.16 Million
KRW
Data as of
Mar 2025
Most recent filing
Ckd Bio Cash Flow Quality Index (2008–2024)
Historical Cash Flow Quality Index for Ckd Bio across 13 annual periods. Values consistently above 1.0x indicate high-quality earnings. For the full cash flow conversion analysis, see cash efficiency ratio of Ckd Bio.
Annual Cash Flow Quality Index for Ckd Bio (2008–2024)
Year-by-year earnings quality comparison for Ckd Bio.
| Year | Quality Index | Operating CF (KRW) | Net Income | YoY Change |
|---|---|---|---|---|
| 2024 | 1.61x | ₩14.03 Billion | ₩8.70 Billion | ▲ +107.5% |
| 2020 | 0.78x | ₩4.82 Billion | ₩6.21 Billion | ▼ -43.9% |
| 2019 | 1.39x | ₩16.99 Billion | ₩12.26 Billion | ▼ -29.1% |
| 2018 | 1.95x | ₩15.54 Billion | ₩7.96 Billion | ▼ -23.4% |
| 2017 | 2.55x | ₩20.45 Billion | ₩8.02 Billion | ▲ +55.2% |
| 2016 | 1.64x | ₩15.50 Billion | ₩9.43 Billion | ▼ -23.8% |
| 2015 | 2.16x | ₩14.34 Billion | ₩6.65 Billion | ▼ -67.3% |
| 2013 | 6.59x | ₩10.92 Billion | ₩1.66 Billion | ▲ +104.4% |
| 2012 | 3.22x | ₩22.90 Billion | ₩7.10 Billion | ▲ +171.7% |
| 2011 | 1.19x | ₩12.96 Billion | ₩10.92 Billion | ▼ -28.6% |
| 2010 | 1.66x | ₩23.89 Billion | ₩14.38 Billion | ▲ +1.2% |
| 2009 | 1.64x | ₩26.57 Billion | ₩16.18 Billion | ▲ +34.2% |
| 2008 | 1.22x | ₩10.69 Billion | ₩8.74 Billion | — |
Cash Flow Quality Index = Operating Cash Flow / Net Income. Ratios above 1.0x indicate cash-backed earnings.